NEW YORK (GenomeWeb News) – NextBio and Genophen today said they are partnering to drive adoption of genomics for disease prevention and wellness.

They said the deal allows Genophen to interpret genomic sequencing data from patients through the use of NextBio's clinical platform and to combine this information with data about a patient's environmental, behavioral, and clinical factors "to create a uniquely tailored disease prevention and wellness plan for its individual member."

Financial and other terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.